This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| Kawasaki | 1478 |
| KD | 1315 |
| SARS | 347 |
| IVIG | 347 |
| COVID-19 | 322 |
| CoV-2 | 260 |
| C | 255 |
| KS | 232 |
| MIS | 184 |
| el | 134 |
| Japan | 134 |
| ANCA | 126 |
| mg | 125 |
| fi | 117 |
| T | 117 |
| Disease | 116 |
| fl | 111 |
| kg | 104 |
| los | 99 |
| GCA | 86 |
| WG | 84 |
| BCG | 75 |
| Association | 73 |
| PAN | 72 |
| anakinra | 70 |
| es | 69 |
| Fig | 69 |
| PCR | 69 |
| enfermedad | 66 |
| ammatory | 62 |
| IgA | 61 |
| IL-1 | 61 |
| kawasaki | 60 |
| un | 59 |
| Table | 59 |
| HLA | 58 |
| ACE2 | 58 |
| HSP | 58 |
| infl | 58 |
| Wegener | 56 |
| CRP | 56 |
| La | 54 |
| IL-6 | 53 |
| infi | 52 |
| China | 52 |
| AAV | 52 |
| TA | 48 |
| ESR | 48 |
| Korea | 47 |
| United | 47 |
| Henoch | 46 |
| defi | 46 |
| las | 45 |
| disease | 44 |
| Taiwan | 44 |
| Coronavirus | 44 |
| del | 43 |
| TNF | 43 |
| States | 43 |
| MPO | 43 |
| American | 42 |
| una | 42 |
| con | 42 |
| en | 38 |
| J | 37 |
| IGHV3 | 37 |
| RT | 36 |
| IgM | 36 |
| Health | 36 |
| BD | 36 |
| ASO | 36 |
| Sweet | 35 |
| Staphylococcus | 34 |
| más | 33 |
| Children | 33 |
| ciency | 32 |
| ITPKC | 32 |
| Heart | 32 |
| sha | 31 |
| PR3 | 31 |
| NLE | 31 |
| GWAS | 31 |
| Epstein | 30 |
| II | 30 |
| PMR | 30 |
| US | 30 |
| USA | 30 |
| casos | 29 |
| S | 29 |
| MPA | 29 |
| como | 28 |
| Italy | 28 |
| CoV | 28 |
| CAAs | 28 |
| Barr | 28 |
| B | 27 |
| Schönlein | 27 |
| PIMS | 27 |
| Supplementary | 27 |
| ammation | 27 |
| fase | 27 |
| rst | 26 |
| UK | 26 |
| Takayasu | 26 |
| Europe | 26 |
| El | 26 |
| A | 26 |
| Multisystem | 25 |
| ASA | 25 |
| DOI | 25 |
| IFN | 25 |
| Syndrome | 25 |
| fiebre | 25 |
| ltrate | 25 |
| su | 25 |
| rs6423677 | 24 |
| WBC | 24 |
| RNA | 24 |
| New | 24 |
| Erythema | 24 |
| IgG | 24 |
| Behçet | 23 |
| S. | 23 |
| CLEC5A | 23 |
| May | 22 |
| puede | 22 |
| CT | 22 |
| HCoV | 22 |
| C. | 22 |
| años | 22 |
| confi | 22 |
| lymphopenia | 22 |
| pero | 21 |
| niños | 21 |
| L | 21 |
| IVIg | 21 |
| IGHV | 21 |
| CD8 | 21 |
| CA | 21 |
| Asia | 21 |
| AHA | 20 |
| Pediatric | 20 |
| Churg | 20 |
| EM | 20 |
| • | 20 |
| aunque | 20 |
| Streptococcus | 20 |
| aneurismas | 19 |
| Schonlein | 19 |
| SNP | 19 |
| Inflammatory | 19 |
| Committee | 19 |
| B19 | 19 |
| ARF | 19 |
| TSS | 19 |
| MAS | 18 |
| April | 18 |
| Dr. | 18 |
| Strauss | 18 |
| por | 18 |
| lesión | 18 |
| ed | 17 |
| America | 17 |
| BNP | 17 |
| India | 17 |
| criterios | 17 |
| diagnóstico | 17 |
| días | 17 |
| lo | 17 |
| methotrexate | 17 |
| ned | 17 |
| parainfluenza | 17 |
| ser | 17 |
| signifi | 17 |
| mm | 17 |
| PACNS | 16 |
| Anakinra | 16 |
| Calmette | 16 |
| Cardiovascular | 16 |
| CoV-1 | 16 |
| MERS | 16 |
| University | 16 |
| SHLH | 16 |
| TMPRSS2 | 16 |
| York | 16 |
| ltrates | 16 |
| α | 16 |
| Hawaii | 15 |
| Council | 15 |
| Epidemiology | 15 |
| NT | 15 |
| CD4 | 15 |
| ALT | 15 |
| June | 15 |
| KDSS | 15 |
| Wuhan | 15 |
| Young | 15 |
| association | 15 |
| enfermos | 15 |
| exantema | 15 |
| infliximab | 15 |
| Treg | 15 |
| Hospital | 14 |
| Lee | 14 |
| ASD | 14 |
| CAA | 14 |
| Diagnosis | 14 |
| East | 14 |
| Fc | 14 |
| Fever | 14 |
| Guérin | 14 |
| North | 14 |
| MRI | 14 |
| SJS | 14 |
| SNV | 14 |
| Tei | 14 |
| Treatment | 14 |
| cient | 14 |
| classifi | 14 |
| effi | 14 |
| protoporphyria | 14 |
| Pediatr | 13 |
| COV-2 | 13 |
| NK | 13 |
| Chang | 13 |
| CSF | 13 |
| Group | 13 |
| CASP3 | 13 |
| Bacillus | 13 |
| ARDS | 13 |
| Society | 13 |
| SAgs | 13 |
| Polyarteritis | 13 |
| Th17 | 13 |
| lesiones | 13 |
| Tregs | 13 |
| rheumatica | 13 |
| prednisone | 13 |
| para | 13 |
| menores | 13 |
| entre | 13 |
| specifi | 13 |
| cation | 13 |
| aguda | 13 |
| síndrome | 13 |
| Homozygous | 12 |
| IL | 12 |
| III | 12 |
| IGH | 12 |
| Human | 12 |
| < | 12 |
| HHV-6 | 12 |
| France | 12 |
| Endocarditis | 12 |
| Control | 12 |
| Cardiac | 12 |
| MEFV | 12 |
| Infl | 12 |
| Rheumatology | 12 |
| Prevention | 12 |
| coronaria | 12 |
| suffi | 12 |
| frecuente | 12 |
| formas | 12 |
| Review | 12 |
| enfermo | 12 |
| artritis | 12 |
| System | 12 |
| SLE | 12 |
| Ro | 12 |
| Rheumatic | 12 |
| January | 11 |
| International | 11 |
| Diego | 11 |
| Esper | 11 |
| Doppler | 11 |
| CINCA | 11 |
| College | 11 |
| CNS | 11 |
| CDC | 11 |
| NL63 | 11 |
| Japanese | 11 |
| HLH | 11 |
| National | 11 |
| autores | 11 |
| RCA | 11 |
| meses | 11 |
| hasta | 11 |
| coronarias | 11 |
| menos | 11 |
| arterias | 11 |
| antineutrophil | 11 |
| superantigens | 11 |
| agent(s | 11 |
| San | 11 |
| IIa | 10 |
| MRA | 10 |
| MLNS | 10 |
| Los | 10 |
| Lack | 10 |
| Imaging | 10 |
| IV | 10 |
| IU | 10 |
| Antineutrophil | 10 |
| February | 10 |
| Covid-19 | 10 |
| Chlamydia | 10 |
| CAWS | 10 |
| Australia | 10 |
| Se | 10 |
| Americans | 10 |
| Acute | 10 |
| NH | 10 |
| Abs | 10 |
| SoJIA | 10 |
| mayor | 10 |
| Study | 10 |
| tratamiento | 10 |
| thrombocytosis | 10 |
| presenta | 10 |
| perivascular | 10 |
| muy | 10 |
| meta | 10 |
| nonspecifi | 10 |
| esta | 10 |
| enfermedades | 10 |
| dosis | 10 |
| diferentes | 10 |
| año | 10 |
| U | 10 |
| TCR | 10 |
| Superantigens | 10 |
| Johnson | 9 |
| South | 9 |
| SA | 9 |
| Report | 9 |
| Prediction | 9 |
| Pediatrics | 9 |
| NOMID | 9 |
| LCWE | 9 |
| Anti | 9 |
| Han | 9 |
| England | 9 |
| Clinical | 9 |
| Center | 9 |
| Candida | 9 |
| CAL | 9 |
| Box | 9 |
| TS | 9 |
| State | 9 |
| annulare | 9 |
| U.S. | 9 |
| myeloperoxidase | 9 |
| ya | 9 |
| tratados | 9 |
| Z | 9 |
| rs28493229 | 9 |
| rm | 9 |
| porphyrias | 9 |
| nodosa | 9 |
| signi | 9 |
| mayores | 9 |
| frecuencia | 9 |
| erythropoietic | 9 |
| descamación | 9 |
| bocavirus | 9 |
| afección | 9 |
| hay | 9 |
| Hong | 8 |
| Findings | 8 |
| G | 8 |
| Genome | 8 |
| Histopathologic | 8 |
| Mycoplasma | 8 |
| I | 8 |
| M | 8 |
| Neutrophil | 8 |
| Epidemiologic | 8 |
| Etanercept | 8 |
| PR3-ANCA | 8 |
| Consortium | 8 |
| Carlo | 8 |
| COV | 8 |
| CCR5 | 8 |
| Behcet | 8 |
| Bacteroides | 8 |
| Adenovirus | 8 |
| Ab | 8 |
| AST | 8 |
| 8) | 8 |
| OC43 | 8 |
| Medical | 8 |
| Protein | 8 |
| kDa | 8 |
| Research | 8 |
| tiene | 8 |
| subaguda | 8 |
| son | 8 |
| pueden | 8 |
| niño | 8 |
| neutrophilic | 8 |
| multicentre | 8 |
| monocyte | 8 |
| le | 8 |
| protoporphyrin | 8 |
| infarto | 8 |
| ares | 8 |
| células | 8 |
| Stevens | 8 |
| VEGF | 8 |
| vasculitis | 8 |
| alteraciones | 8 |
| aumento | 8 |
| benefi | 8 |
| cacy | 8 |
| clínicos | 8 |
| Monte | 7 |
| SS | 7 |
| Mycobacterium | 7 |
| Nationwide | 7 |
| Pathogenesis | 7 |
| SNPs | 7 |
| YO | 7 |
| SST | 7 |
| Stage | 7 |
| Tomisaku | 7 |
| Turkey | 7 |
| Vβ | 7 |
| Kobayashi | 7 |
| March | 7 |
| C3 | 7 |
| IL-1β | 7 |
| Genetics | 7 |
| European | 7 |
| Erythropoietic | 7 |
| Development | 7 |
| DNA | 7 |
| Cogan | 7 |
| CoVs | 7 |
| Characteristics | 7 |
| CSS | 7 |
| COVID | 7 |
| algunos | 7 |
| Board | 7 |
| Appendix | 7 |
| Yersinia | 7 |
| Prednisone | 7 |
| anterior | 7 |
| identifi | 7 |
| arthralgias | 7 |
| veces | 7 |
| vasa | 7 |
| todos | 7 |
| tocilizumab | 7 |
| si | 7 |
| mycophenolate | 7 |
| muffi | 7 |
| mofetil | 7 |
| lymph | 7 |
| linfocitos | 7 |
| les | 7 |
| labios | 7 |
| inflammasome | 7 |
| según | 7 |
| habitualmente | 7 |
| ecografía | 7 |
| características | 7 |
| gm | 7 |
| diferencial | 7 |
| diffi | 7 |
| duración | 7 |
| durante | 7 |
| difícil | 7 |
| enrojecimiento | 7 |
| eritema | 7 |
| este | 7 |
| estudios | 7 |
| gammaglobulina | 7 |
| Immunoglobulin | 6 |
| IBD | 6 |
| Las | 6 |
| Institutional | 6 |
| Jordan | 6 |
| Kim | 6 |
| Kingdom | 6 |
| Korean | 6 |
| Kyung | 6 |
| LCA | 6 |
| Molecular | 6 |
| M. | 6 |
| Management | 6 |
| Microbiota | 6 |
| Middle | 6 |
| Ministry | 6 |
| Novel | 6 |
| PDGF | 6 |
| Purpura | 6 |
| HUVS | 6 |
| SD | 6 |
| Hyperinflammatory | 6 |
| Cardiology | 6 |
| HIV | 6 |
| H1N1 | 6 |
| TGF | 6 |
| ABO | 6 |
| APS | 6 |
| Angiotensin | 6 |
| Associated | 6 |
| CD40 | 6 |
| CDR3 | 6 |
| Case | 6 |
| Centers | 6 |
| Chandigarh | 6 |
| City | 6 |
| Crohn | 6 |
| DIC | 6 |
| Diseases | 6 |
| ECMO | 6 |
| EPP | 6 |
| En | 6 |
| Esta | 6 |
| GI | 6 |
| Spain | 6 |
| erythema | 6 |
| TLR2 | 6 |
| proteinase-3 | 6 |
| multiorgan | 6 |
| nan | 6 |
| neonatale | 6 |
| ni | 6 |
| nuestra | 6 |
| periungual | 6 |
| pleocytosis | 6 |
| polymyalgia | 6 |
| profi | 6 |
| rs4774175 | 6 |
| interleukin-1 | 6 |
| se | 6 |
| sera | 6 |
| también | 6 |
| uno | 6 |
| uroporphyrinogen | 6 |
| vasorum | 6 |
| ± | 6 |
| TT | 6 |
| À5 | 6 |
| lymphohistiocytosis | 6 |
| superantigen | 6 |
| immunodefi | 6 |
| está | 6 |
| aparición | 6 |
| identi | 6 |
| Villegas | 6 |
| cial | 6 |
| conjuntivitis | 6 |
| desquamation | 6 |
| dilatación | 6 |
| encontró | 6 |
| después | 6 |
| etanercept | 6 |
| hepatomegaly | 6 |
| etiología | 6 |
| exantemas | 6 |
| fulfi | 6 |
| fulminans | 6 |
| h. | 6 |
| hyperinflammatory | 6 |
| han | 6 |
| MDL-1 | 5 |
| Lactobacilli | 5 |
| LV | 5 |
| LD | 5 |
| LCCWE | 5 |
| Kussmaul | 5 |
| Kawa | 5 |
| Kong | 5 |
| Institutes | 5 |
| KO | 5 |
| JKL | 5 |
| Italian | 5 |
| Malaysia | 5 |
| Involvement | 5 |
| Maier | 5 |
| PCT | 5 |
| Muckle | 5 |
| Multi | 5 |
| NP | 5 |
| Netherlands | 5 |
| Newburger | 5 |
| Onouchi | 5 |
| Outcomes | 5 |
| PE | 5 |
| Pacific | 5 |
| Polymorphisms | 5 |
| Polymyalgia | 5 |
| PubMed | 5 |
| REOF | 5 |
| Incomplete | 5 |
| RITUXIVAS | 5 |
| Infliximab | 5 |
| CMV | 5 |
| Incidence | 5 |
| IgE | 5 |
| SPE | 5 |
| A. | 5 |
| AHE | 5 |
| Analysis | 5 |
| Asians | 5 |
| B51 | 5 |
| BLK | 5 |
| Beijing | 5 |
| Bergamo | 5 |
| Burgner | 5 |
| CD14 | 5 |
| Caucasians | 5 |
| DRB1 | 5 |
| Diagnostic | 5 |
| Drug | 5 |
| ELISA | 5 |
| Effect | 5 |
| Este | 5 |
| FCU | 5 |
| Faecalibacterium | 5 |
| Front | 5 |
| Glucocorticoids | 5 |
| Guidelines | 5 |
| HCoVs | 5 |
| Hay | 5 |
| Herpes | 5 |
| Histologic | 5 |
| ICU | 5 |
| IL-18 | 5 |
| Rowley | 5 |
| myalgias | 5 |
| SPSS | 5 |
| lengua | 5 |
| leukocytosis | 5 |
| methylprednisolone | 5 |
| miocardio | 5 |
| momento | 5 |
| mucosas | 5 |
| otro | 5 |
| otros | 5 |
| países | 5 |
| periarteritis | 5 |
| plaquetas | 5 |
| polymorphonuclear | 5 |
| posteriores | 5 |
| primeros | 5 |
| seguimiento | 5 |
| semanas | 5 |
| series | 5 |
| signos | 5 |
| sistémica | 5 |
| sus | 5 |
| síntomas | 5 |
| toxin-1 | 5 |
| trimethoprim | 5 |
| type | 5 |
| vascular | 5 |
| ácido | 5 |
| íntima | 5 |
| −8 | 5 |
| ≥5 | 5 |
| September | 5 |
| leucocytosis | 5 |
| tarda | 5 |
| insuffi | 5 |
| autoinfl | 5 |
| Serologic | 5 |
| incompletas | 5 |
| TDI | 5 |
| TLR | 5 |
| Type | 5 |
| Una | 5 |
| Zhemo | 5 |
| a1111111111 | 5 |
| acetilsalicílico | 5 |
| algunas | 5 |
| ampollas | 5 |
| antiphospholipid | 5 |
| arthropathy | 5 |
| atrophicans | 5 |
| Wells | 5 |
| cm | 5 |
| día | 5 |
| hepatosplenomegaly | 5 |
| comienzo | 5 |
| herpes | 5 |
| hepatitis | 5 |
| hLAMP-2 | 5 |
| edad | 5 |
| hemophagocytic | 5 |
| du | 5 |
| dl | 5 |
| dermoepidermal | 5 |
| debe | 5 |
| conjuntival | 5 |
| NGS | 4 |
| Lactobacillus | 4 |
| NIH | 4 |
| NFKD | 4 |
| nan | 4 |
| Measles | 4 |
| Marshall | 4 |
| MWS | 4 |
| Ling | 4 |
| Latin | 4 |
| Infectious | 4 |
| LMWH | 4 |
| Koplik | 4 |
| July | 4 |
| JYW | 4 |
| Infection | 4 |
| Impact | 4 |
| IgD | 4 |
| IL-2 | 4 |
| Neutrophilic | 4 |
| IL-1α | 4 |
| NLRP3 | 4 |
| SAs | 4 |
| Northern | 4 |
| Rickettsia | 4 |
| IL-10 | 4 |
| Trial | 4 |
| Tocilizumab | 4 |
| Thrombocytopenia | 4 |
| TAJ | 4 |
| Sjögren | 4 |
| Scientific | 4 |
| SSA | 4 |
| Ruminococcus | 4 |
| Rheumatol | 4 |
| Organization | 4 |
| Reye | 4 |
| Results | 4 |
| Recognition | 4 |
| RHD | 4 |
| Prevotella | 4 |
| Periungual | 4 |
| Park | 4 |
| PMIS | 4 |
| Ozen | 4 |
| IL-17 | 4 |
| Canada | 4 |
| IL)-6 | 4 |
| CCL3L1 | 4 |
| Corticosteroids | 4 |
| CoV2 | 4 |
| Chronic | 4 |
| Chen | 4 |
| Care | 4 |
| Ca | 4 |
| CTCA | 4 |
| CMH | 4 |
| CEP | 4 |
| CC | 4 |
| Cyclosporin | 4 |
| Blueberry | 4 |
| Beau | 4 |
| Alert | 4 |
| Akagawa | 4 |
| African | 4 |
| Academy | 4 |
| ADE | 4 |
| 2DE | 4 |
| Un | 4 |
| Coxsackie | 4 |
| Dahdah | 4 |
| ID-19 | 4 |
| Evaluation | 4 |
| IBM | 4 |
| Hepatoerythropoietic | 4 |
| Haven | 4 |
| HCoV-229E | 4 |
| Fox | 4 |
| Finland | 4 |
| Figure | 4 |
| FAM167A | 4 |
| Existe | 4 |
| EpsteineBarr | 4 |
| December | 4 |
| Eosinophilia | 4 |
| English | 4 |
| Ehrlichia | 4 |
| Efficacy | 4 |
| EULAR | 4 |
| EED | 4 |
| E | 4 |
| Dis | 4 |
| Design | 4 |
| Tropospheric | 4 |
| Propionibacterium | 4 |
| Urticaria | 4 |
| node | 4 |
| primera | 4 |
| presencia | 4 |
| posibilidad | 4 |
| período | 4 |
| pequeñas | 4 |
| palmoplantar | 4 |
| origen | 4 |
| ocasiones | 4 |
| nv | 4 |
| ng | 4 |
| proteína | 4 |
| neutrophilia | 4 |
| mycobacterial | 4 |
| media | 4 |
| ltrative | 4 |
| junction | 4 |
| inyección | 4 |
| infecciosa | 4 |
| infancia | 4 |
| importante | 4 |
| proBNP | 4 |
| reactantes | 4 |
| harderoporphyria | 4 |
| syndrome | 4 |
| Usefulness | 4 |
| virus | 4 |
| varía | 4 |
| uorescence | 4 |
| transmembrane | 4 |
| transiens | 4 |
| toxina | 4 |
| temporal | 4 |
| sólo | 4 |
| superantígeno | 4 |
| respuesta | 4 |
| suma | 4 |
| subungueal | 4 |
| sino | 4 |
| serum | 4 |
| serologic | 4 |
| segunda | 4 |
| sea | 4 |
| riesgo | 4 |
| rhinorrhea | 4 |
| importancia | 4 |
| tóxico | 4 |
| haber | 4 |
| aquagenic | 4 |
| control | 4 |
| colchicine | 4 |
| classi | 4 |
| casi | 4 |
| canakinumab | 4 |
| vivo | 4 |
| cambios | 4 |
| autoantibody | 4 |
| así | 4 |
| antígeno | 4 |
| cryocrit | 4 |
| anticardiolipin | 4 |
| amoxicillin | 4 |
| amed | 4 |
| agentes | 4 |
| aframbuesada | 4 |
| aetiopathogenesis | 4 |
| Western | 4 |
| grupo | 4 |
| Washington | 4 |
| coronarios | 4 |
| World | 4 |
| descrito | 4 |
| estos | 4 |
| diagnósticos | 4 |
| graves | 4 |
| gigantes | 4 |
| grandes | 4 |
| genera | 4 |
| formación | 4 |
| extremidades | 4 |
| evolución | 4 |
| estudio | 4 |
| expansión | 4 |
| estenosis | 4 |
| elevación | 4 |
| diferencias | 4 |
| doc_id | 4 |
| estafilocócica | 4 |
| ef | 4 |
| ectasia | 4 |
| enteroviruses | 4 |
| escarlatina | 4 |
| ese | 4 |
| Mb | 3 |
| Med | 3 |
| Mediterranean | 3 |
| Memory | 3 |
| Methotrexate | 3 |
| Mi | 3 |
| Myocarditis | 3 |
| Min | 3 |
| PLT | 3 |
| NAPlr | 3 |
| Nagata | 3 |
| Nature | 3 |
| Network | 3 |
| O | 3 |
| ORAI1 | 3 |
| Oligoclonal | 3 |
| Oregon | 3 |
| PRES | 3 |
| MTX | 3 |
| Kuo | 3 |
| MMP-9 | 3 |
| MMF | 3 |
| Invader | 3 |
| PTT | 3 |
| Islanders | 3 |
| J. | 3 |
| Japón | 3 |
| Jean | 3 |
| Journal | 3 |
| K | 3 |
| KAICA | 3 |
| Kg | 3 |
| Kinumaki | 3 |
| Klebsiella | 3 |
| LAD | 3 |
| LDH | 3 |
| Laboratory | 3 |
| Les | 3 |
| Lupus | 3 |
| MAF | 3 |
| MHC | 3 |
| PRINTO | 3 |
| Sars | 3 |
| Pandemic | 3 |
| También | 3 |
| Silk | 3 |
| Springer | 3 |
| Structure | 3 |
| Su | 3 |
| Superantigen | 3 |
| TCRV | 3 |
| TTE | 3 |
| Taiwanese | 3 |
| TaqMan | 3 |
| Seasonality | 3 |
| Team | 3 |
| Telangiectasia | 3 |
| Thrombocytosis | 3 |
| Tokyo | 3 |
| Toll | 3 |
| Typical | 3 |
| Ultrastructural | 3 |
| Infections | 3 |
| Shimizu | 3 |
| Science | 3 |
| Parvovirus | 3 |
| Purpuric | 3 |
| Pathology | 3 |
| Pentoxifylline | 3 |
| Persistence | 3 |
| Persistent | 3 |
| Por | 3 |
| Porphyrias | 3 |
| Presentation | 3 |
| Project | 3 |
| RANTES | 3 |
| ST | 3 |
| RUNX3 | 3 |
| Response | 3 |
| Rituximab | 3 |
| Road | 3 |
| Rolando | 3 |
| Roseburia | 3 |
| S2 | 3 |
| SNVs | 3 |
| Interleukin-1 | 3 |
| Detection | 3 |
| Induction | 3 |
| Cyclophosphamide | 3 |
| Chi | 3 |
| Chicago | 3 |
| Chinese | 3 |
| Cimaz | 3 |
| CoV-1/2 | 3 |
| CoV. | 3 |
| Coronary | 3 |
| County | 3 |
| Cytoplasmic | 3 |
| Centre | 3 |
| D | 3 |
| D. | 3 |
| DCs | 3 |
| Darier | 3 |
| David | 3 |
| Department | 3 |
| V. | 3 |
| EBV | 3 |
| Cerebrospinal | 3 |
| Central | 3 |
| Immunosuppression | 3 |
| Assay | 3 |
| -3 | 3 |
| 21C | 3 |
| ALAD | 3 |
| ALC | 3 |
| Adjunctive | 3 |
| Antibiotic | 3 |
| Arthralgias | 3 |
| Arthus | 3 |
| Assessment | 3 |
| COPD | 3 |
| Azathioprine | 3 |
| BCR | 3 |
| Bacille | 3 |
| Burns | 3 |
| C4 | 3 |
| CD28 | 3 |
| CD4-positive | 3 |
| CHAT | 3 |
| ECG | 3 |
| EUVAS | 3 |
| Endothelial | 3 |
| Hospitalized | 3 |
| HSV | 3 |
| Harada | 3 |
| Hb | 3 |
| Hee | 3 |
| Herpesvirus | 3 |
| High | 3 |
| Histopathological | 3 |
| Ho | 3 |
| Host | 3 |
| Enfermedad | 3 |
| Huang | 3 |
| I. | 3 |
| IGHD | 3 |
| IGHJ | 3 |
| IL-8 | 3 |
| Illness | 3 |
| Illumina | 3 |
| Immunology | 3 |
| HKU1 | 3 |
| HHV‐6 | 3 |
| H7N9 | 3 |
| H3K27me3 | 3 |
| Es | 3 |
| Escherichia | 3 |
| Ethics | 3 |
| Existen | 3 |
| F | 3 |
| FCGR | 3 |
| FDA | 3 |
| FMF | 3 |
| Familial | 3 |
| Features | 3 |
| GB | 3 |
| Genomes | 3 |
| GnRH | 3 |
| Granuloma | 3 |
| Granulomatosis | 3 |
| Gung | 3 |
| Gunther | 3 |
| V | 3 |
| Consensus | 3 |
| Vb | 3 |
| nombre | 3 |
| mitad | 3 |
| modi | 3 |
| mononeuritis | 3 |
| mucositis | 3 |
| multiforme | 3 |
| nacional | 3 |
| necrópsicos | 3 |
| neutrofilia | 3 |
| nueva | 3 |
| metalloproteinase-3 | 3 |
| número | 3 |
| ocurre | 3 |
| ocurrir | 3 |
| opinión | 3 |
| oralis | 3 |
| otras | 3 |
| papilledema | 3 |
| pemphigoid | 3 |
| metapneumovirus | 3 |
| metagenomic | 3 |
| pentoxifylline | 3 |
| lactantes | 3 |
| incremento | 3 |
| inicial | 3 |
| intenso | 3 |
| intravenosa | 3 |
| investigadores | 3 |
| iximab | 3 |
| junto | 3 |
| l'épidémie | 3 |
| leucocitos | 3 |
| mejor | 3 |
| leucocitosis | 3 |
| lopinavir | 3 |
| luz | 3 |
| líquido | 3 |
| manera | 3 |
| manifiesta | 3 |
| manos | 3 |
| medallones | 3 |
| pensar | 3 |
| pequeños | 3 |
| incidencia | 3 |
| todas | 3 |
| serie | 3 |
| signo | 3 |
| siguientes | 3 |
| sobre | 3 |
| speci | 3 |
| tabla | 3 |
| tamaño | 3 |
| thromboplastin | 3 |
| trascendencia | 3 |
| scleritis | 3 |
| treg | 3 |
| trombocitosis | 3 |
| uid | 3 |
| unas | 3 |
| vía | 3 |
| © | 3 |
| −9 | 3 |
| Viral | 3 |
| secuelas | 3 |
| rs2857151 | 3 |
| perfusión | 3 |
| proteínas | 3 |
| perinuclear | 3 |
| permite | 3 |
| podido | 3 |
| polimorfos | 3 |
| porphyria | 3 |
| profilaxis | 3 |
| proin | 3 |
| protein-1 | 3 |
| publicación | 3 |
| rituximab | 3 |
| pyrin | 3 |
| quinto | 3 |
| rara | 3 |
| reactiva | 3 |
| realiza | 3 |
| recientemente | 3 |
| reticularis | 3 |
| revisión | 3 |
| incluso | 3 |
| periférico | 3 |
| immunoassays | 3 |
| ce | 3 |
| boca | 3 |
| bronchoalveolar | 3 |
| c. | 3 |
| cantly | 3 |
| capa | 3 |
| cardíacas | 3 |
| case | 3 |
| caso | 3 |
| cefaclor | 3 |
| audiovestibular | 3 |
| centrifugum | 3 |
| ciencies | 3 |
| clínicas | 3 |
| complicaciones | 3 |
| coproporphyria | 3 |
| creemos | 3 |
| criterio | 3 |
| cryoglobulinemia | 3 |
| bene | 3 |
| antes | 3 |
| cutanea | 3 |
| activación | 3 |
| Viruses | 3 |
| hypocomplementemia | 3 |
| WGET | 3 |
| Wei | 3 |
| West | 3 |
| YM | 3 |
| Yi | 3 |
| Yu | 3 |
| adenitis | 3 |
| antecedente | 3 |
| adenopathy | 3 |
| adultos | 3 |
| aftas | 3 |
| agudo | 3 |
| alanine | 3 |
| alrededor | 3 |
| alteración | 3 |
| ans | 3 |
| cryoglobulinemias | 3 |
| author(s | 3 |
| dapsone | 3 |
| gran | 3 |
| excepcional | 3 |
| experiencia | 3 |
| expresión | 3 |
| febril | 3 |
| ferrochelatase | 3 |
| final | 3 |
| fue | 3 |
| genomewide | 3 |
| granulomatosis | 3 |
| estándar | 3 |
| ha | 3 |
| hace | 3 |
| hallazgo | 3 |
| herpesvirus-6 | 3 |
| histopathologic | 3 |
| hydrops | 3 |
| hydroxychloroquine | 3 |
| hyperimmune | 3 |
| etiopathogenesis | 3 |
| g/ | 3 |
| difíciles | 3 |
| desarrollados | 3 |
| especialmente | 3 |
| desconocida | 3 |
| desde | 3 |
| detectar | 3 |
| dehydratase | 3 |
| distribución | 3 |
| eHealth | 3 |
| elevada | 3 |
| elevatum | 3 |
| ello | 3 |
| encuentra | 3 |
| encuentran | 3 |
| engrosamiento | 3 |
| entidades | 3 |
| escaldadura | 3 |
| escuela | 3 |
| esos | 3 |
| Matsubara | 2 |
| Measurement | 2 |
| Memorial | 2 |
| Meta | 2 |
| MCLS | 2 |
| Methylenetetrahydrofolate | 2 |
| Mokdong | 2 |
| Mortality | 2 |
| Maryland | 2 |
| Mutation | 2 |
| Matrix | 2 |
| MICA | 2 |
| Maria | 2 |
| Mann | 2 |
| MagNA | 2 |
| Macrophage | 2 |
| MPD | 2 |
| MMPs | 2 |
| MMP | 2 |
| MEDLINE | 2 |
| Ménière | 2 |
| Muy | 2 |
| Paris | 2 |
| NCT02390596 | 2 |
| PAX2 | 2 |
| MA | 2 |
| Patient | 2 |
| Pathergy | 2 |
| Patients | 2 |
| Para | 2 |
| Paediatric | 2 |
| PT | 2 |
| PR3-and | 2 |
| PR | 2 |
| P322L | 2 |
| NET | 2 |
| P3-positive | 2 |
| P | 2 |
| Otitis | 2 |
| Note | 2 |
| Neonatal | 2 |
| Nagib | 2 |
| NYC | 2 |
| NY | 2 |
| NFAT | 2 |
| MASP2 | 2 |
| Int | 2 |
| Lyme | 2 |
| Ireland | 2 |
| John | 2 |
| Jin | 2 |
| Jessica | 2 |
| Jen | 2 |
| Jae | 2 |
| Jacob | 2 |
| JPT | 2 |
| Italians | 2 |
| Israel | 2 |
| Intravenous | 2 |
| Jung | 2 |
| Intervention | 2 |
| Interleukin | 2 |
| Interferon | 2 |
| Intensive | 2 |
| Inositol | 2 |
| Influenza | 2 |
| Immunoregulatory | 2 |
| Immunol | 2 |
| Peptostreptococcus | 2 |
| Jones | 2 |
| Justine | 2 |
| Luminal | 2 |
| Lancet | 2 |
| Long | 2 |
| Loci | 2 |
| Literature | 2 |
| Lin | 2 |
| Lim | 2 |
| License | 2 |
| Li | 2 |
| Leukocytosis | 2 |
| Le | 2 |
| LYH | 2 |
| KAWAKINRA | 2 |
| LT | 2 |
| LM | 2 |
| LCX | 2 |
| LC | 2 |
| L. | 2 |
| Kimata | 2 |
| Kenneth | 2 |
| Kawasakilike | 2 |
| Kaneko | 2 |
| Paul | 2 |
| Th-1 | 2 |
| Perianal | 2 |
| Pericarditis | 2 |
| Surjit | 2 |
| Supplemental | 2 |
| Superantigenic | 2 |
| Sung | 2 |
| Subacute | 2 |
| Stone | 2 |
| Statistics | 2 |
| Staphylococci | 2 |
| Spectrum | 2 |
| Soret | 2 |
| Son | 2 |
| Single | 2 |
| Singh | 2 |
| Simpson | 2 |
| Severe | 2 |
| Seul | 2 |
| Service | 2 |
| Serology | 2 |
| Sera | 2 |
| Scleritis | 2 |
| Sainte | 2 |
| Susanna | 2 |
| Sweden | 2 |
| TCRBV2-and | 2 |
| Immune | 2 |
| Tsuji | 2 |
| Tsai | 2 |
| Trimethoprimsulfamethoxazole | 2 |
| Total | 2 |
| Todo | 2 |
| Tissue | 2 |
| Thoracic | 2 |
| Therapy | 2 |
| Thalidomide | 2 |
| Tertiary | 2 |
| TCRBV6-bearing | 2 |
| Term | 2 |
| Temporal | 2 |
| Takeshita | 2 |
| Taesung | 2 |
| TSST-1 | 2 |
| TNF)-α | 2 |
| TLRs | 2 |
| TH | 2 |
| TGFB | 2 |
| STC | 2 |
| SLCA20 | 2 |
| SLC11A1 | 2 |
| Predictors | 2 |
| Question | 2 |
| QT | 2 |
| Pyuria | 2 |
| Pure | 2 |
| Public | 2 |
| Protection | 2 |
| Pro | 2 |
| Primary | 2 |
| Presence | 2 |
| Poyiadi | 2 |
| R | 2 |
| Porphyrie | 2 |
| Polyclonal | 2 |
| Pleural | 2 |
| Pityriasis | 2 |
| Pinzani | 2 |
| Ping | 2 |
| Philips | 2 |
| Petechiae | 2 |
| Perivascular | 2 |
| Quizá | 2 |
| RCHSD | 2 |
| SFB | 2 |
| Rev | 2 |
| SEG | 2 |
| SCFAs | 2 |
| SARS‐CoV‐2 | 2 |
| Roche | 2 |
| Rilonacept | 2 |
| Rigante | 2 |
| Rickettsiae | 2 |
| Rheumatoid | 2 |
| Rh | 2 |
| Republic | 2 |
| RCTs | 2 |
| Rep | 2 |
| Remdesivir | 2 |
| Relationship | 2 |
| Receptor | 2 |
| Rady | 2 |
| Racial | 2 |
| ROS | 2 |
| REOF4 | 2 |
| REOF3 | 2 |
| Immunofl | 2 |
| Cytokine | 2 |
| Ill | 2 |
| Igualmente | 2 |
| COVID‐19 | 2 |
| COVID19 | 2 |
| COVID-19-associated | 2 |
| COPRO | 2 |
| CI | 2 |
| CHC | 2 |
| CECs | 2 |
| CD4þ | 2 |
| CD26 | 2 |
| CD25+CD4 | 2 |
| CASE | 2 |
| CALs | 2 |
| Bullous | 2 |
| Brief | 2 |
| Blood | 2 |
| Biomed | 2 |
| Bergame | 2 |
| Baselli | 2 |
| Barré | 2 |
| BY | 2 |
| BCRs | 2 |
| CPP | 2 |
| CTCF | 2 |
| California | 2 |
| Clostridium | 2 |
| Complement | 2 |
| Comparative | 2 |
| Commons | 2 |
| Commentary | 2 |
| Commensal | 2 |
| Colorado | 2 |
| Colcott | 2 |
| Colchicine | 2 |
| CoV-2-specific | 2 |
| Clinics | 2 |
| Cazzaniga | 2 |
| Clinicaltrials.gov | 2 |
| ClinicalTrials.gov | 2 |
| Chun | 2 |
| Ching | 2 |
| Childhood | 2 |
| Chien | 2 |
| Chiao | 2 |
| Chest | 2 |
| Chapter | 2 |
| BALF | 2 |
| BAL | 2 |
| BACNS | 2 |
| ACE-2 | 2 |
| Academia | 2 |
| APSGN | 2 |
| ANAKID | 2 |
| ANA | 2 |
| AM | 2 |
| AIDS | 2 |
| ADH | 2 |
| ACR | 2 |
| ACE2-angiotensin | 2 |
| ACE)-2 | 2 |
| Además | 2 |
| A1 | 2 |
| 3B | 2 |
| 3A | 2 |
| 2D | 2 |
| 16S | 2 |
| -definition | 2 |
| -6 | 2 |
| -4 | 2 |
| URO | 2 |
| Activation | 2 |
| Administration | 2 |
| BACKGROUND | 2 |
| Aphthous | 2 |
| B3 | 2 |
| B. | 2 |
| B*5201 | 2 |
| Autoimmunity | 2 |
| Autoantibodies | 2 |
| Audrey | 2 |
| Attribution | 2 |
| Atopic | 2 |
| Arch | 2 |
| Antibody | 2 |
| Adolescents | 2 |
| Anne | 2 |
| Anna | 2 |
| Angioedema | 2 |
| Andover | 2 |
| Americana | 2 |
| Al | 2 |
| Ai | 2 |
| Agency | 2 |
| Age | 2 |
| Congenital | 2 |
| Conjunctival | 2 |
| Consent | 2 |
| H. | 2 |
| Heterologous | 2 |
| Hematologic | 2 |
| Heat | 2 |
| Healthcare | 2 |
| Harnden | 2 |
| Hardy | 2 |
| HSP65 | 2 |
| HCV | 2 |
| H5N1 | 2 |
| H&E | 2 |
| Histopathology | 2 |
| Günter | 2 |
| Gut | 2 |
| Guillain | 2 |
| Guez | 2 |
| Guerin | 2 |
| Gram | 2 |
| Godman | 2 |
| Giovanni | 2 |
| Gangdong | 2 |
| Hispanics | 2 |
| Hitherto | 2 |
| G614 | 2 |
| IL-1Ra | 2 |
| IgA1 | 2 |
| IVMP | 2 |
| IVCT | 2 |
| ISG | 2 |
| IRB | 2 |
| INF | 2 |
| IL-4 | 2 |
| IL-2R | 2 |
| IL-22 | 2 |
| IL-1RA | 2 |
| Home | 2 |
| IL-1R | 2 |
| IIb | 2 |
| IGHV4 | 2 |
| IGHC | 2 |
| IE33 | 2 |
| ID | 2 |
| ICM | 2 |
| Hydrops | 2 |
| Hsps | 2 |
| GC | 2 |
| Fisher | 2 |
| Coronaviridae | 2 |
| DR4 | 2 |
| Dionne | 2 |
| Diagnostics | 2 |
| Dermatology | 2 |
| Dermatol | 2 |
| Departments | 2 |
| Dellepiane | 2 |
| Data | 2 |
| DY | 2 |
| DVT | 2 |
| D614 | 2 |
| Donato | 2 |
| Cytomegalovirus | 2 |
| CsA | 2 |
| Creative | 2 |
| Creactive | 2 |
| CpG | 2 |
| Coxsackievirus | 2 |
| Coxiella | 2 |
| Corticosteroid | 2 |
| Coronaviruses | 2 |
| Discrimination | 2 |
| Dong | 2 |
| FimH | 2 |
| Esposito | 2 |
| Fate | 2 |
| Far | 2 |
| Falk | 2 |
| Exantema | 2 |
| Ewha | 2 |
| Eubacterium | 2 |
| Estos | 2 |
| Esto | 2 |
| Estas | 2 |
| España | 2 |
| Dr | 2 |
| Erythrocyte | 2 |
| Eruptions | 2 |
| Erdal | 2 |
| Enterococcus | 2 |
| Enterobacteriaceae | 2 |
| Echocardiogram | 2 |
| EKG | 2 |
| ECHO | 2 |
| Dysbiosis | 2 |
| U.K. | 2 |
| Investigation | 2 |
| UROGEN | 2 |
| porphobilinogen | 2 |
| oscuro | 2 |
| orofaríngea | 2 |
| oral | 2 |
| ont | 2 |
| oligoclonal | 2 |
| observó | 2 |
| nuestro | 2 |
| nudosa | 2 |
| novo | 2 |
| normalizan | 2 |
| normales | 2 |
| normal | 2 |
| nonacute | 2 |
| nodosum | 2 |
| nitions | 2 |
| ningún | 2 |
| ninguno | 2 |
| nephropathy | 2 |
| n=94 | 2 |
| n=44 | 2 |
| multisystemic | 2 |
| otra | 2 |
| ow | 2 |
| owner(s | 2 |
| persiste | 2 |
| policlonal | 2 |
| podemos | 2 |
| plantas | 2 |
| planta | 2 |
| piuria | 2 |
| pies | 2 |
| piensa | 2 |
| pharyngoconjunctival | 2 |
| persistente | 2 |
| permanente | 2 |
| p=0.001 | 2 |
| periféricos | 2 |
| perforin | 2 |
| pañal | 2 |
| patient | 2 |
| par | 2 |
| papillitis | 2 |
| palmas | 2 |
| palma | 2 |
| p=0.027 | 2 |
| mucosa | 2 |
| mucocutáneo | 2 |
| mucho | 2 |
| juvenil | 2 |
| leukocytoclasis | 2 |
| leukocyte | 2 |
| laxa | 2 |
| lateral | 2 |
| laminar | 2 |
| lactante | 2 |
| l'enfant | 2 |
| key | 2 |
| kb | 2 |
| japonesa | 2 |
| linfocito | 2 |
| involutive | 2 |
| interleukin-6 | 2 |
| interleukin-4 | 2 |
| insuficiencia | 2 |
| inmunidad | 2 |
| inicialmente | 2 |
| iniciales | 2 |
| inicia | 2 |
| infiltrados | 2 |
| lichenoid | 2 |
| livedo | 2 |
| ms | 2 |
| medRxiv | 2 |
| mortalidad | 2 |
| morbilliform | 2 |
| mononuclear | 2 |
| monogenic | 2 |
| mismo | 2 |
| miocarditis | 2 |
| minimac | 2 |
| milia | 2 |
| microangiopathy | 2 |
| matrix | 2 |
| llega | 2 |
| manifestación | 2 |
| manifestaciones | 2 |
| macrófago | 2 |
| mRNA | 2 |
| mL | 2 |
| lymphoplasmacytic | 2 |
| lymphadenitis | 2 |
| lupus | 2 |
| lowdose | 2 |
| polyarteritis | 2 |
| posterior | 2 |
| infantil | 2 |
| presentación | 2 |
| urticarial | 2 |
| urticaria | 2 |
| uorescein | 2 |
| típica | 2 |
| très | 2 |
| trombos | 2 |
| trombocitopenia | 2 |
| tipo | 2 |
| tienen | 2 |
| territorios | 2 |
| territorio | 2 |
| tercer | 2 |
| tenía | 2 |
| tenido | 2 |
| tardías | 2 |
| tardía | 2 |
| tarde | 2 |
| síntoma | 2 |
| surco | 2 |
| supone | 2 |
| superficie | 2 |
| varias | 2 |
| varios | 2 |
| varones | 2 |
| éstas | 2 |
| ≥38.0 | 2 |
| URTI | 2 |
| ≥2 | 2 |
| ≥ | 2 |
| −4 | 2 |
| −/− | 2 |
| γ | 2 |
| única | 2 |
| último | 2 |
| à | 2 |
| vasculares | 2 |
| × | 2 |
| µg | 2 |
| warfarin | 2 |
| visfatin | 2 |
| vida | 2 |
| vez | 2 |
| velocidad | 2 |
| vegan | 2 |
| vaso | 2 |
| superfi | 2 |
| superantígenos | 2 |
| sulphamethoxazole | 2 |
| pulmonary | 2 |
| receptor | 2 |
| realizar | 2 |
| realizado | 2 |
| rash | 2 |
| range | 2 |
| quemado | 2 |
| queda | 2 |
| pérdida | 2 |
| purifi | 2 |
| publicados | 2 |
| refl | 2 |
| publicado | 2 |
| pseudovirus | 2 |
| pseudopneumoniae | 2 |
| propio | 2 |
| propia | 2 |
| procesado | 2 |
| principalmente | 2 |
| presión | 2 |
| presentó | 2 |
| reciente | 2 |
| refs | 2 |
| sulfamethoxazole | 2 |
| secos | 2 |
| suele | 2 |
| stridor | 2 |
| sospechas | 2 |
| significativas | 2 |
| siempre | 2 |
| sentido | 2 |
| semana | 2 |
| segundo | 2 |
| sedimentación | 2 |
| sarampión | 2 |
| relacionada | 2 |
| rmed | 2 |
| rmatory | 2 |
| ritonavir | 2 |
| rilonacept | 2 |
| rheumatoid | 2 |
| revistas | 2 |
| restantes | 2 |
| respiratoria | 2 |
| remdesivir | 2 |
| infecciosas | 2 |
| postcapillary | 2 |
| inespecífica | 2 |
| autoinflammatory | 2 |
| cadena | 2 |
| cada | 2 |
| burneti | 2 |
| brusca | 2 |
| brinoid | 2 |
| brinogen | 2 |
| brin | 2 |
| azithromycin | 2 |
| avec | 2 |
| atric | 2 |
| característica | 2 |
| aspirina | 2 |
| asintomático | 2 |
| articulaciones | 2 |
| arthralgia | 2 |
| aquellos | 2 |
| aparecen | 2 |
| aortitis | 2 |
| anómala | 2 |
| antistreptolysin | 2 |
| cambiante | 2 |
| carditis | 2 |
| antigen(s | 2 |
| completas | 2 |
| coronariopatía | 2 |
| coro | 2 |
| coproporphyrin | 2 |
| convalecencia | 2 |
| considera | 2 |
| conocidas | 2 |
| conjunctivae | 2 |
| comunes | 2 |
| complicación | 2 |
| complejo | 2 |
| caspase-3 | 2 |
| colesterol | 2 |
| clínico | 2 |
| cliniques | 2 |
| clavulanic | 2 |
| chloroquine | 2 |
| chez | 2 |
| cepas | 2 |
| central | 2 |
| causado | 2 |
| antiinflamatorias | 2 |
| antigen | 2 |
| creen | 2 |
| Vβ2 | 2 |
| Yang | 2 |
| Y. | 2 |
| Xray | 2 |
| Wu | 2 |
| Working | 2 |
| Womans | 2 |
| Whitney | 2 |
| Weinberg | 2 |
| W. | 2 |
| Virus | 2 |
| Yin | 2 |
| Verdoni | 2 |
| Vegetant | 2 |
| Variations | 2 |
| Vancomycin | 2 |
| VV | 2 |
| Uveitis | 2 |
| Use | 2 |
| individuos | 2 |
| Unrecognized | 2 |
| Yil | 2 |
| Yoon | 2 |
| anti-60 | 2 |
| alta | 2 |
| anti-52 | 2 |
| angiográfico | 2 |
| angiography | 2 |
| angiografía | 2 |
| angiitis | 2 |
| aneurisma | 2 |
| analysis | 2 |
| ambos | 2 |
| ambas | 2 |
| alt_abnormal | 2 |
| abciximab | 2 |
| ahora | 2 |
| agrietados | 2 |
| afecta | 2 |
| adquirida | 2 |
| adhesión | 2 |
| adenopatías | 2 |
| adenopatía | 2 |
| acompañada | 2 |
| acompaña | 2 |
| crecimiento | 2 |
| antiinflamatorios | 2 |
| gordonii | 2 |
| estreptocócica | 2 |
| grados | 2 |
| gene | 2 |
| ganglionar | 2 |
| gamma | 2 |
| g. | 2 |
| fácilmente | 2 |
| futuras | 2 |
| fuertes | 2 |
| fth | 2 |
| frecuentemente | 2 |
| forman | 2 |
| fetalis | 2 |
| falta | 2 |
| factor | 2 |
| exudativa | 2 |
| existen | 2 |
| exclusiva | 2 |
| excepto | 2 |
| exanthema | 2 |
| exantemáticas | 2 |
| exactitud | 2 |
| groupe | 2 |
| gure | 2 |
| gyratum | 2 |
| hospital | 2 |
| indefi | 2 |
| inclina | 2 |
| crohn | 2 |
| immunopathogenesis | 2 |
| immunofl | 2 |
| idiopática | 2 |
| hypoalbuminemia | 2 |
| hyperferritinemia | 2 |
| hpf | 2 |
| historia | 2 |
| haematuria | 2 |
| Ultrasonography | 2 |
| hipótesis | 2 |
| hipotensión | 2 |
| herpesviruses | 2 |
| herpesvirus | 2 |
| hepáticas | 2 |
| hepatopatía | 2 |
| heavy | 2 |
| hallazgos | 2 |
| estéril | 2 |
| fallecidos | 2 |
| data | 2 |
| echovirus | 2 |
| diámetro | 2 |
| discreta | 2 |
| dif | 2 |
| diagnosticados | 2 |
| detoxifi | 2 |
| desaparece | 2 |
| datos | 2 |
| estas | 2 |
| dado | 2 |
| d. | 2 |
| cytoplasm | 2 |
| cytomegalovirus | 2 |
| cutáneas | 2 |
| cutis | 2 |
| cumplían | 2 |
| cuando | 2 |
| cualquier | 2 |
| cuales | 2 |
| cual | 2 |
| cuadro | 2 |
| cryoglobulins | 2 |
| e. | 2 |
| diferenciales | 2 |
| ectasias | 2 |
| endotheliitis | 2 |
| escarlatiniforme | 2 |
| esas | 2 |
| esa | 2 |
| eritrodermia | 2 |
| enzyme | 2 |
| enzimas | 2 |
| enterotypes | 2 |
| estar | 2 |
| enoxaparin | 2 |
| endotelio | 2 |
| endoteliales | 2 |
| endotelial | 2 |
| encontrado | 2 |
| enantema | 2 |
| ellos | 2 |
| ella | 2 |
| edades | 2 |
| especiales | 2 |
| Northeastern | 1 |
| Norfolk | 1 |
| Norway | 1 |
| Nsp12 | 1 |
| Nunca | 1 |
| Nucleic | 1 |
| Nucleotide | 1 |
| Null | 1 |
| Number | 1 |
| Nonmedical | 1 |
| Nonspecifi | 1 |
| Neutropaenia | 1 |
| Noncommunicable | 1 |
| Non | 1 |
| Nikolski | 1 |
| Nikibakhsh | 1 |
| Nicolai | 1 |
| Nicola | 1 |
| Nicholas | 1 |
| Newborns | 1 |
| Neutrophils | 1 |
| Nursing | 1 |
| Nur | 1 |
| Mosby | 1 |
| OC16 | 1 |
| OC37 | 1 |
| Options | 1 |
| Nervous | 1 |
| OpenSAFELY | 1 |
| Open | 1 |
| Online | 1 |
| Oncology | 1 |
| Oligonal | 1 |
| Ohno | 1 |
| Ogata | 1 |
| Ofrecemos | 1 |
| Oedème | 1 |
| October | 1 |
| Oceania | 1 |
| Occlusions | 1 |
| Occlu | 1 |
| Observational | 1 |
| ORF8 | 1 |
| ORF3b | 1 |
| ORF1ab | 1 |
| ORF-1-NSP7/13-specific | 1 |
| OC48-were | 1 |
| Neuro | 1 |
| Motivation | 1 |
| Nelson | 1 |
| Necmettin | 1 |
| Más | 1 |
| Myocardial | 1 |
| Myeloid | 1 |
| Mycoplasmae | 1 |
| MyD88 | 1 |
| Muthuvelu | 1 |
| Mutations | 1 |
| Murine | 1 |
| Multiforme | 1 |
| Multiethnic | 1 |
| Multicenter | 1 |
| Mulitsystem | 1 |
| Mucosal | 1 |
| Mucocutaneous | 1 |
| Ms. | 1 |
| Movie | 1 |
| Mouse | 1 |
| Mountain | 1 |
| Mount | 1 |
| Moss | 1 |
| Orr | 1 |
| Ménière's | 1 |
| N | 1 |
| N. | 1 |
| NYSDOH | 1 |
| Natural | 1 |
| Natriuretic | 1 |
| Natasha | 1 |
| Nat | 1 |
| Nasal | 1 |
| Narrowband | 1 |
| Narrative | 1 |
| Narchi | 1 |
| Nakra | 1 |
| NSAIDs | 1 |
| NAALADL2 | 1 |
| NOD1 | 1 |
| NLRs | 1 |
| NKRF | 1 |
| NETs | 1 |
| NC_000014.8 | 1 |
| NCV | 1 |
| NCT2179853 | 1 |
| NCT01431105 | 1 |
| NASEM | 1 |
| Orenstein | 1 |
| Products | 1 |
| Orthogonal | 1 |
| Pollak | 1 |
| Pneumocystis | 1 |
| Planned | 1 |
| Pitzer | 1 |
| Pityrosporum | 1 |
| Pitriasis | 1 |
| Pipeline | 1 |
| Pino | 1 |
| Pin | 1 |
| Pilania | 1 |
| Phylogenetic | 1 |
| Phototoxic | 1 |
| Photosensitivity | 1 |
| Photodermatology | 1 |
| Philadelphia | 1 |
| Phase | 1 |
| Pharmacokinetics | 1 |
| Peterson | 1 |
| Petechial | 1 |
| Pero | 1 |
| Permite | 1 |
| Peripherical | 1 |
| Polinori | 1 |
| Polyarticular | 1 |
| Performance | 1 |
| Porphyria | 1 |
| Prospective | 1 |
| Morbilliform | 1 |
| Propylthiouracil | 1 |
| Proposed | 1 |
| Professionals | 1 |
| Procoagulant | 1 |
| Problems | 1 |
| Principi | 1 |
| PrimeScript | 1 |
| Prevalence | 1 |
| Preexisting | 1 |
| Pre | 1 |
| Practice | 1 |
| Prac | 1 |
| Poupart | 1 |
| Pouletty | 1 |
| Potts | 1 |
| Potential | 1 |
| Possible | 1 |
| Portland | 1 |
| Porphyrin | 1 |
| Pericardial | 1 |
| Pendergraft | 1 |
| Oscar | 1 |
| PRISMA | 1 |
| PPE | 1 |
| PMCMR | 1 |
| PLoS | 1 |
| PIMSTS | 1 |
| PICU | 1 |
| PET | 1 |
| PEG | 1 |
| PCNSV | 1 |
| PBMCs | 1 |
| P=0.003 | 1 |
| P<0.001 | 1 |
| P72 | 1 |
| P41 | 1 |
| P. | 1 |
| P- | 1 |
| Ozsurekci | 1 |
| Ozaki | 1 |
| Overview | 1 |
| Overlap | 1 |
| Ou | 1 |
| Osler | 1 |
| PR-3 | 1 |
| PRR | 1 |
| Pei | 1 |
| PRRs | 1 |
| Pediatría | 1 |
| Payer | 1 |
| Paut | 1 |
| Patrick | 1 |
| Pathophysiology | 1 |
| Pathogenicity | 1 |
| Pathogen | 1 |
| Party | 1 |
| Partnership | 1 |
| Parkinson | 1 |
| Papilledema | 1 |
| Pape | 1 |
| Pap | 1 |
| Paolino | 1 |
| Palma | 1 |
| Pajno | 1 |
| Paediatr | 1 |
| PUVA | 1 |
| PU.1 | 1 |
| PTPN | 1 |
| PReS | 1 |
| Morbillivirus | 1 |
| Jang | 1 |
| Morbiliform | 1 |
| Laurel | 1 |
| Langerhans | 1 |
| Lan | 1 |
| LambdaMuSigma | 1 |
| Lakshminrusimha | 1 |
| Laboratories | 1 |
| La. | 1 |
| LY6E | 1 |
| LVET | 1 |
| LPS | 1 |
| LLC | 1 |
| LIR7 | 1 |
| LILRA2 | 1 |
| LDM | 1 |
| LCC | 1 |
| Kyle | 1 |
| Kurian | 1 |
| Kumar | 1 |
| Kuender | 1 |
| Kubo | 1 |
| Kruskal | 1 |
| Krugman | 1 |
| Langhans | 1 |
| Lehmann | 1 |
| Koreans | 1 |
| Leucemie | 1 |
| Low | 1 |
| Louis | 1 |
| London | 1 |
| Localized | 1 |
| Loads | 1 |
| Livido | 1 |
| Liver | 1 |
| Liu | 1 |
| Liszewski | 1 |
| Lisa | 1 |
| Lind | 1 |
| Limitation | 1 |
| Limelight | 1 |
| Light | 1 |
| Licciardi | 1 |
| Library | 1 |
| Liang | 1 |
| Lewontin | 1 |
| Levels | 1 |
| Leung | 1 |
| Leucocyte | 1 |
| Kouichi | 1 |
| Kone | 1 |
| Lu | 1 |
| JordanVillegas | 1 |
| Jonckheere | 1 |
| Jonathan | 1 |
| Jocelyn | 1 |
| Jiulliana | 1 |
| Jiménez | 1 |
| Jilin | 1 |
| Jia | 1 |
| Ji | 1 |
| Jer | 1 |
| Jeong | 1 |
| Jennifer | 1 |
| Jennette | 1 |
| Janus | 1 |
| Proteinase-3 | 1 |
| Janet | 1 |
| Jane | 1 |
| Jan | 1 |
| Jaggi | 1 |
| Jagadeesh | 1 |
| JRA | 1 |
| JP18ek0410039 | 1 |
| Jong | 1 |
| Ju | 1 |
| Kikuchi | 1 |
| Julie | 1 |
| Khor | 1 |
| Key | 1 |
| Kev | 1 |
| Keuk | 1 |
| Kesici | 1 |
| Kazunari | 1 |
| Kaya | 1 |
| Kawaski | 1 |
| Kawasakidisease | 1 |
| Kaustubh | 1 |
| Kato | 1 |
| Kaoru | 1 |
| Kaohsiung | 1 |
| Kansai | 1 |
| Kang | 1 |
| KYL | 1 |
| KSCL | 1 |
| KI | 1 |
| KDR | 1 |
| KAWAK | 1 |
| Jörg | 1 |
| Ltd. | 1 |
| Luan | 1 |
| Moolani | 1 |
| Microaneurysms | 1 |
| Michiaki | 1 |
| MiSeq | 1 |
| Mexico | 1 |
| Methods | 1 |
| Methemoglobinemia | 1 |
| Metabolites | 1 |
| Memoire | 1 |
| Meloche | 1 |
| Melissa | 1 |
| Mei | 1 |
| Meeting | 1 |
| Medium | 1 |
| Medicine | 1 |
| Mechanisms | 1 |
| McIntosh | 1 |
| Mauro | 1 |
| Maurice | 1 |
| Matzniger | 1 |
| Mathew | 1 |
| Material | 1 |
| Materia | 1 |
| Micro | 1 |
| Microbiologic | 1 |
| MassARRAY | 1 |
| Microbiome | 1 |
| Montreal | 1 |
| Montenegro | 1 |
| Montañas | 1 |
| Mononuclear | 1 |
| Mononeuritis | 1 |
| Monocyte | 1 |
| Mohd | 1 |
| Mohan | 1 |
| Modified | 1 |
| Modifi | 1 |
| Modi | 1 |
| Miura | 1 |
| Miranda | 1 |
| Mini | 1 |
| Ming | 1 |
| Millennium | 1 |
| Mihaylo | 1 |
| Mientras | 1 |
| Midwives | 1 |
| Midwest | 1 |
| Microphthalmia | 1 |
| Masuda | 1 |
| Mashimo | 1 |
| Lucas | 1 |
| MK2 | 1 |
| MIA | 1 |
| MESNA | 1 |
| MDCT | 1 |
| MDC | 1 |
| MCP1 | 1 |
| MCLNS | 1 |
| MC | 1 |
| MB | 1 |
| MASP2-binding | 1 |
| MASP2-N | 1 |
| MAP | 1 |
| Léamarie | 1 |
| Lymphocyte | 1 |
| Lymphnode | 1 |
| Lymphadenopathy | 1 |
| Lymphadenitis | 1 |
| Luigi | 1 |
| Luen | 1 |
| Luego | 1 |
| Lucy | 1 |
| Lucia | 1 |
| MK | 1 |
| MMP-3 | 1 |
| María | 1 |
| MMP3/ | 1 |
| Martín | 1 |
| Marta | 1 |
| Marseille | 1 |
| Markers | 1 |
| Mark | 1 |
| Marie | 1 |
| Marfan | 1 |
| Marco | 1 |
| Marburg | 1 |
| Manus | 1 |
| Mantoux | 1 |
| Manson | 1 |
| Manlhiot | 1 |
| Manhattan | 1 |
| Malaysian | 1 |
| Malaria | 1 |
| Maggio | 1 |
| Madrid | 1 |
| Macaca | 1 |
| MYCYC | 1 |
| MMP9 | 1 |
| Proteinase | 1 |
| Statement | 1 |
| Proteolytic | 1 |
| Three | 1 |
| Therapeutics | 1 |
| Therapeutic | 1 |
| Ther | 1 |
| Thelper | 1 |
| Thailand | 1 |
| Th2 | 1 |
| Th17s | 1 |
| Th17/ | 1 |
| Th17-and | 1 |
| Th-2 | 1 |
| Text | 1 |
| Terpstra | 1 |
| Terms | 1 |
| Teresa | 1 |
| Ter | 1 |
| Temiz | 1 |
| Temecula | 1 |
| Television | 1 |
| Tecumseh | 1 |
| Tchana | 1 |
| Tcell | 1 |
| Thomson | 1 |
| Thrombosis | 1 |
| Tatsuhiko | 1 |
| Times | 1 |
| Tuberculosis | 1 |
| Tsunoda | 1 |
| Tsui | 1 |
| Tsong | 1 |
| Troponin | 1 |
| Triggers | 1 |
| Tricuspid | 1 |
| Tremoulet | 1 |
| Translational | 1 |
| Transcriptomic | 1 |
| Transcriptional | 1 |
| Toxicities | 1 |
| Toshiro | 1 |
| Toshihiro | 1 |
| Torrelo | 1 |
| Toolkit | 1 |
| Tomasaku | 1 |
| Tohru | 1 |
| Toddlers | 1 |
| Todd | 1 |
| Ting | 1 |
| Taxonomy | 1 |
| Targets | 1 |
| Turnier | 1 |
| TEM | 1 |
| TCRs | 1 |
| TAKARA | 1 |
| T2 | 1 |
| T. | 1 |
| Systems | 1 |
| Systemic | 1 |
| Symposium | 1 |
| Syk | 1 |
| Sydney | 1 |
| Switzerland | 1 |
| Suzuki | 1 |
| Suzanne | 1 |
| Surveys | 1 |
| Surveillance | 1 |
| Surgery | 1 |
| Sungai | 1 |
| Sun | 1 |
| Summary | 1 |
| Sum | 1 |
| Suganuma | 1 |
| Suenaga | 1 |
| TDT | 1 |
| TEN | 1 |
| Target | 1 |
| TGF)-β | 1 |
| Taoyuan | 1 |
| Tanaka | 1 |
| Tampoco | 1 |
| Tamar | 1 |
| Takahisa | 1 |
| Takahashi | 1 |
| Tai | 1 |
| Tachycardia | 1 |
| Tables | 1 |
| TP | 1 |
| TNF | 1 |
| TNFalpha | 1 |
| TNFR1 | 1 |
| TMPTSS2 | 1 |
| TLR9 | 1 |
| TLR7 | 1 |
| TL-01 | 1 |
| TIMPs | 1 |
| TIMP1 | 1 |
| THP-1 | 1 |
| TGFBR2 | 1 |
| Turgeon | 1 |